Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | pyruvate kinase 1 | 0.0034 | 0.0278 | 1 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0034 | 0.0278 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0076 | 0.3853 | 0.3699 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.04 | 0.0498 |
Plasmodium vivax | pyruvate kinase, putative | 0.0034 | 0.0278 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0071 | 0.3456 | 0.4439 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0034 | 0.0278 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0118 | 0.7437 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0278 | 0.0038 |
Loa Loa (eye worm) | pyruvate kinase | 0.0034 | 0.0278 | 0.0038 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0034 | 0.0294 | 0.0366 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0034 | 0.0278 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.04 | 0.5 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.0034 | 0.0294 | 0.0022 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.9283 | 1 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0034 | 0.0278 | 0.0036 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0894 | 0.1112 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0034 | 0.0278 | 0.5 |
Leishmania major | pyruvate kinase | 0.0034 | 0.0278 | 1 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0034 | 0.0294 | 0.0366 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0034 | 0.0278 | 0.5 |
Loa Loa (eye worm) | pyruvate kinase | 0.0034 | 0.0278 | 0.0038 |
Giardia lamblia | Pyruvate kinase | 0.0034 | 0.0278 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.04 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0294 | 0.0056 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0041 | 0.0894 | 0.0719 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0045 | 0.1214 | 0.1306 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.04 | 0.0498 |
Chlamydia trachomatis | pyruvate kinase | 0.0034 | 0.0278 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0034 | 0.0294 | 0.0022 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.1542 | 0.1331 |
Brugia malayi | PHD-finger family protein | 0.0049 | 0.161 | 0.1401 |
Schistosoma mansoni | bromodomain containing protein | 0.0125 | 0.8037 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0034 | 0.0294 | 0.0366 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.4261 | 0.4444 |
Schistosoma mansoni | pyruvate kinase | 0.0034 | 0.0278 | 0.0346 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0034 | 0.0278 | 0.5 |
Plasmodium falciparum | pyruvate kinase | 0.0034 | 0.0278 | 0.5 |
Echinococcus granulosus | zinc finger protein | 0.0039 | 0.0717 | 0.0612 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0034 | 0.0278 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.04 | 0.5 |
Echinococcus multilocularis | zinc finger protein | 0.0039 | 0.0717 | 0.0612 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.3864 | 0.4006 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.04 | 0.017 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.1542 | 0.1437 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0034 | 0.0278 | 0.5 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0034 | 0.0278 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0244 | 0.0303 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0034 | 0.0278 | 1 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0034 | 0.0294 | 0.0366 |
Leishmania major | pyruvate kinase | 0.0034 | 0.0278 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0071 | 0.3456 | 0.4439 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0118 | 0.7437 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0039 | 0.0717 | 0.0891 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0034 | 0.0294 | 0.0022 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.1542 | 0.1331 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0045 | 0.1214 | 0.151 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0034 | 0.0278 | 0.0036 |
Schistosoma mansoni | pyruvate kinase | 0.0034 | 0.0278 | 0.0346 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0034 | 0.0278 | 0.5 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0035 | 0.0397 | 0.0169 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.0034 | 0.0294 | 0.0022 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.4581 | 0.4798 |
Loa Loa (eye worm) | pyruvate kinase | 0.0034 | 0.0278 | 0.0038 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0045 | 0.1214 | 0.1306 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.04 | 0.017 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1542 | 0.1437 |
Mycobacterium ulcerans | pyruvate kinase | 0.0034 | 0.0278 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.04 | 0.5 |
Brugia malayi | hypothetical protein | 0.0035 | 0.04 | 0.016 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.9 uM | Inhibition of alpha-MSH-induced melanin production in mouse B16 cells after 72 hrs | ChEMBL. | 20097083 |
Inhibition (functional) | > 100 % | Inhibition of alpha-MSH-induced melanin production in mouse B16 cells at 10 uM after 72 hrs | ChEMBL. | 20097083 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 20097083 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.